Filing Details
- Accession Number:
- 0001140361-13-034095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-26 10:38:13
- Reporting Period:
- 2013-08-22
- Filing Date:
- 2013-08-26
- Accepted Time:
- 2013-08-26 10:38:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
890846 | Uroplasty Inc | UPI | Surgical & Medical Instruments & Apparatus (3841) | 411719250 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1323150 | Brett Reynolds | 5420 Feltl Rd Minnetonka MN 55343 | Senior V.p. Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-08-22 | 3,700 | $2.93 | 53,700 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2013-08-23 | 4,300 | $3.04 | 58,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | non-qualified stock options | $2.97 | 2014-08-12 | 2021-08-11 | 100,000 | 100,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-08-11 | 100,000 | 100,000 | Direct |
Footnotes
- Becomes exercisable with respect to one-third of the shares on the first, second and third anniversaries of the grant date (the grant date being one year prior to such date).
- Includes 50,000 shares of restricted stock subject to risk of forfeiture that lapses with respect to one third of such shares on each of the first, second and third anniversaries of the grant date (August 12, 2013).
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.865 to $2.95 per share, inclusive.